These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9740075)

  • 1. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors.
    Kovatich A; Friedland DM; Druck T; Hadaczek P; Huebner K; Comis RL; Hauck W; McCue PA
    Cancer; 1998 Sep; 83(6):1109-17. PubMed ID: 9740075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
    Hurr K; Kemp B; Silver SA; el-Naggar AK
    Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
    D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
    Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic changes in the spectrum of neuroendocrine lung tumors.
    Onuki N; Wistuba II; Travis WD; Virmani AK; Yashima K; Brambilla E; Hasleton P; Gazdar AF
    Cancer; 1999 Feb; 85(3):600-7. PubMed ID: 10091733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
    Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
    Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosome arm 11q in lung carcinoids.
    Petzmann S; Ullmann R; Klemen H; Renner H; Popper HH
    Hum Pathol; 2001 Mar; 32(3):333-8. PubMed ID: 11274644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
    Yanagisawa K; Kondo M; Osada H; Uchida K; Takagi K; Masuda A; Takahashi T; Takahashi T
    Cancer Res; 1996 Dec; 56(24):5579-82. PubMed ID: 8971157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
    Sozzi G; Tornielli S; Tagliabue E; Sard L; Pezzella F; Pastorino U; Minoletti F; Pilotti S; Ratcliffe C; Veronese ML; Goldstraw P; Huebner K; Croce CM; Pierotti MA
    Cancer Res; 1997 Dec; 57(23):5207-12. PubMed ID: 9393735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular abnormalities associated with endocrine tumors of the uterine cervix.
    Wistuba II; Thomas B; Behrens C; Onuki N; Lindberg G; Albores-Saavedra J; Gazdar AF
    Gynecol Oncol; 1999 Jan; 72(1):3-9. PubMed ID: 9889022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.
    Ullmann R; Schwendel A; Klemen H; Wolf G; Petersen I; Popper HH
    Hum Pathol; 1998 Oct; 29(10):1145-9. PubMed ID: 9781656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormalities of tumor suppressor genes at chromosome 3p in lung cancer].
    Li L; An Q; Feng X
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):399-401. PubMed ID: 11798905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.
    Geradts J; Fong KM; Zimmerman PV; Minna JD
    Br J Cancer; 2000 Mar; 82(6):1191-7. PubMed ID: 10735505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inactivation of caspase-8 in lung cancers.
    Shivapurkar N; Toyooka S; Eby MT; Huang CX; Sathyanarayana UG; Cunningham HT; Reddy JL; Brambilla E; Takahashi T; Minna JD; Chaudhary PM; Gazdar AF
    Cancer Biol Ther; 2002; 1(1):65-9. PubMed ID: 12170765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
    Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
    Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Fhit protein expression in human malignant mesothelioma.
    Pylkkänen L; Wolff H; Stjernvall T; Knuuttila A; Anttila S; Husgafvel-Pursiainen K
    Virchows Arch; 2004 Jan; 444(1):43-8. PubMed ID: 14569398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
    Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
    Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.